The Global Prepacked Chromatography Columns Market Continues To Grow Owing To the Expansion of Biotechnology Laboratories in the World
Prepacked
chromatography columns are column-like structures containing various chemical
substances that are utilized as conductors. When a compound is passed through
the column, these chemicals usually react chemically with one another or with
any other components in the compound. The information in the chemical reaction
is collected by the column's various nozzles and collected within the column's
body. This information is valuable to pharmacists and other clinical scientists
who need this information for experimental purposes.
The
prepackaged chromatography columns available for sale in the market are
designed for use in various types of laboratories, including those in the
pharmaceutical industry. Because of their versatility and ability to suit
various purposes, these chemical-free columns have been gaining much favor in
the commercial world. The processing and packaging of chromatography-based
compounds have now become standard in the medical and food industries,
especially with the growing demands in the food and processed food market
growth. Chromatography-based products are generally easy to process and provide
the user with reliable and consistent results.
Increased
expansion of biotechnology labs all over the world is driving the growth of the
global prepacked chromatography columns market. For instance, according to
Biotechgate, there are over 19,936 registered biotech companies in the world,
and according to India Brand Equity Foundation, in 2019 there were more than
2700 biotech start-up companies in India. Moreover, the increasing research and
development activities along with the launch of several biopharmaceutical drugs
are also aiding the growth of the global prepacked
chromatography columns market.
With
increased demands for effective and reliable quality measures in pharmaceutical
production and the food and beverage market, the demand for reliable and
economical laboratory equipment continues to grow. Chromatography-based
products serve as an affordable and effective means of chromatin purification and
analysis in the pharmaceutical industry. They also contribute to the effective
management of hazardous materials in the downstream processes. Many leading
pharmaceutical companies invest a significant amount of money in the research
and development of new and cost-efficient equipment that contribute to quality
improvement across the board. As a result of this investment, many of these
companies can create cost-effective and efficient processes that eliminate
unnecessary steps and consequently improve the efficiency of the entire
downstream process. However, clogging and fouling in prepacked chromatography
columns are limiting the growth of the global prepacked chromatography columns
market.
Owing
to the increase of biotechnology labs in the region, North America is
witnessing high demand in the global prepacked chromatography columns market.
For instance, according to the Biotechnology Innovation Organization, there are
currently over 2349 private and public biotechnology companies in the United
States. Moreover, the advancement in the healthcare sector of the region is
also augmenting the growth of the market. Owing to such factors, there have
been some significant industrial developments in the global prepacked
chromatography columns market. For instance, in May 2018, the U.S. Food and
Drug Administration (FDA) approved a biosimilar to Epogen and Procrit, called
RETACRIT, which was developed by Pfizer, Inc.

Comments
Post a Comment